Early but promising results lead to Phase II national trial
MD Anderson News Release 05/31/14
Poster # 3516
CHICAGO — In an aggressive disease known for poor response rates, researchers from The University of Texas MD Anderson Cancer Center found patients with advanced colorectal cancer responded well to a combination therapy of the drugs vermurafenib, cetuximab and irinotecan.
The Phase I trial, presented...
Unique, robust method uses family data to find mutations for both common and rare diseases
MD Anderson News Release 05/30/14...
Study findings could impact standard of care beyond breast cancer
MD Anderson News Release 05/30/14
Women with metastatic...
Former Secretary of State Condoleezza Rice takes stage with Fox News Channel’s Brit Hume
MD Anderson News Release 05/28/14
Dr. Condoleezza Rice was the honoree of The University of Texas MD Anderson Cancer Center’s A Conversation With a Living Legend®, Wednesday, May 21 at the Westin Galleria. Significantly surpassing all past years’ fundraising totals for the Houston event, it attracted 930 guests and raised more than...
Treatment completed without breaks, hospitalizations; results suggest proton therapy may be useful in management of head and neck tumors
Study identifies risk of chemotherapy related hospitalization for early-stage breast cancer patients
MD Anderson News Release 05/27/14
Oncologists now have a new understanding of the toxicity levels of specific chemotherapy regimens...
Peptide antibodies hit immune-response-stifling MDSCs without harming other vital cells
MD Anderson News Release 05/25/14
...
Study shows fibrosis summons an immune attack, challenges theory that it blocks chemotherapy
MD Anderson News Release 05/22/14
MD Anderson News Release 05/20/14
In an effort to combat lung cancer and other serious diseases, The University of Texas MD Anderson...